This is a Validated Antibody Database (VAD) review about rat Mlkl, based on 2 published articles (read how Labome selects the articles), using Mlkl antibody in all methods. It is aimed to help Labome visitors find the most suited Mlkl antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mlkl synonym: mixed lineage kinase domain-like protein; rCG51567-like

Knockout validation
Biorbyt
rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; loading ...; fig s2c
  • western blot knockout validation; mouse; loading ...; fig s2c
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
Biorbyt Mlkl antibody (Biorbyt, orb32399) was used in immunohistochemistry knockout validation on mouse samples (fig s2c), in western blot knockout validation on mouse samples (fig s2c) and in immunohistochemistry - paraffin section on mouse samples (fig 2c). J Clin Invest (2016) ncbi
Biorbyt
rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; loading ...; fig s2c
  • western blot knockout validation; mouse; loading ...; fig s2c
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2c
Biorbyt Mlkl antibody (Biorbyt, orb32399) was used in immunohistochemistry knockout validation on mouse samples (fig s2c), in western blot knockout validation on mouse samples (fig s2c) and in immunohistochemistry - paraffin section on mouse samples (fig 2c). J Clin Invest (2016) ncbi
Sigma-Aldrich
rabbit polyclonal
  • western blot; human; fig 5a,b
Sigma-Aldrich Mlkl antibody (Sigma-Aldrich, 2103620) was used in western blot on human samples (fig 5a,b). Cell Commun Signal (2015) ncbi
Articles Reviewed
  1. Günther C, He G, Kremer A, Murphy J, Petrie E, Amann K, et al. The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. J Clin Invest. 2016;126:4346-4360 pubmed publisher
  2. Philipp S, Sosna J, Plenge J, Kalthoff H, Adam D. Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis. Cell Commun Signal. 2015;13:25 pubmed publisher